Welcome to our book review site go-pdf.online!
You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.
Breast Fitness
Never before has a book so clearly detailed how exercise can reduce the risk for and recurrence of breast cancer, and how women can incorporate a safe and effective exercise program into their lives to fight against the disease. In clear, accessible language, the expert authors explain: *How to ascertain your breast cancer risk factors *What you can do NOW to prevent Breast Cancer *Detailed diet and exercise programs that will keep you healthy and can save your life *How to detect breast cancer early *Your best lifestyle choices for surviving--and thriving--after diagnosis, and practical steps to maximize your chances of the cancer never coming back. Want to prevent breast cancer or keep it from coming back? With Breast Fitness, Dr. Anne McTiernan, Dr. Julie Gralow, and Dr. Lisa Talbott present the only comprehensive, illustrated guide to the new-found connection between exercise and fighting breast cancer, and what you can do to maximize your chances of living your life breast cancer-free.
Beauty without the Breast
Felicia Knaul, an economist who has lived and worked for two decades in Latin America on health and social development, documents the personal and professional sides of her breast cancer experience. Beauty without the Breast contrasts her difficult but inspiring journey with that of the majority of women throughout the world who face not only the disease but stigma, discrimination, and lack of access to health care. This wrenching contrast is the cancer divide—an equity imperative in global health. Knaul exposes barriers affecting women in low and middle-income countries and highlights the role of men, family, and community in responding to the challenge of breast cancer. She shares striki...
Closing the Cancer Divide
Cancer has become a leading cause of death and disability and a serious yet unforeseen challenge to health systems in low-and middle-income countries. A protracted and polarized cancer transition is under way and fuels a concentration of preventable risk, illness, suffering, impoverishment from ill health, and death among poor populations. Closing this cancer divide is an equity imperative. The world faces a huge, unperceived cost of failure to take action that requires an immediate and large-scale global response. Closing the Cancer Divide presents strategies for innovation in delivery, pricing, procurement, finance, knowledge-building, and leadership that can be scaled up by applying a dia...
Negotiating Structural Vulnerability in Cancer Control
What can case studies about the lived experiences of cancer contribute to an interest in the concept of structural vulnerability? And can a consideration of structural vulnerability enhance applied anthropological work in cancer prevention and control? To answer these questions the contributors in this volume explore what it means to be structurally vulnerable; how structural vulnerabilities intersect with cancer risk, diagnosis, care seeking, caregiving, clinical-trial participation, and survivorship; and how differing local, national, and global political contexts and histories inform vulnerability. These case studies illustrate how quotidian experiences of structural vulnerability influence and are altered by a cancer diagnosis at various points in the continuum of care. In examining cancer as a set of diseases and biosocial phenomena, the contributors extend structural vulnerability beyond its original conceptualization to encompass spatiality, temporality, and biosocial shifts in both individual and institutional arrangements.
Drugs and the FDA
How the FDA was shaped by public health crises and patient advocacy, told against a background of the contentious hearings on the breast cancer drug Avastin. Food and Drug Administration approval for COVID-19 vaccines and the controversial Alzheimer’s drug Aduhelm made headlines, but few of us know much about how the agency does its work. Why is the FDA the ultimate US authority on a drug’s safety and efficacy? In Drugs and the FDA, Mikkael Sekeres—a leading oncologist and former chair of the FDA’s cancer drug advisory committee—tells the story of how the FDA became the most trusted regulatory agency in the world. It took a series of tragedies and health crises, as well as patient ...
Cancer and the Politics of Care
This timely volume responds to the epic impacts of cancer as a global phenomenon. Through the fine-grained lens of ethnography, the contributors present new thinking on how social, economic, race, gender and other structural inequalities intersect, compound and complicate health inequalities. Cancer experiences and impacts are explored across eleven countries: Argentina, Brazil, Denmark, France, Greece, India, Indonesia, Italy, Senegal, the United Kingdom and the United States. The volume engages with specific cancers from the point of primary prevention, to screening, diagnosis, treatment (or its absence), and end-of-life care. Cancer and the Politics of Care traverses new theoretical terra...
Global Oncology: Disparities, Outcomes and Innovations Around the Globe, An Issue of Hematology/Oncology Clinics of North America, E-Book
In this issue of Hematology/Oncology Clinics, guest editors Drs. Mary D. Chamberlin and Narjust Duma bring theirconsiderable expertise to the topic of Global Oncology: Disparities, Outcomes and Innovations Around the Globe. The first section of this issue is non-disease site-specific, covering broad topics that influence global health and oncology in various world regions, such as disparities, political unrest, the role of ASCO and ICEC and other organizations for education and research collaborations, access to training and innovations, etc. The second section is disease site-specific (lung, CNS, lymphoma, etc.), addressing approaches to prevention, access to treatment, survivorship, pallia...
